Decreased α-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's diseas
Authors:
- 1 August 1995
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 1 (8) , 829-832
Abstract
The neuropathologic hallmarks of Alzheimer's disease (AD) are extracellular plaques and intracellular neurofibrillary tangles. A constituent of senile plaques in AD is β-amyloid, a hydrophobic peptide of 39–43 amino acids1 and a fragment of the amyloid precursor protein (APP). APP can be metabolized by at least two pathways, one of which involves generation of soluble APP by an unidentified enzyme named α-secretase. This cleavage generates α-secretase-cleaved, soluble APP (α–sAPP), which in this investigation was measured by a new assay in cerebrospinal fluid (CSF) from members of a Swedish AD family with a pathogenic mutation at APP670/671 (ref. 2). Family members who carry the mutation and are diagnosed with AD had low levels of α–sAPP (160 ± 48 ng ml−1), with no overlap compared with non-carriers (257 ± 48 ng ml−1). Carriers of the presymptomatic mutation showed intermediate α–sAPP levels. Today there exists no antemortem marker in AD with sufficient sensitivity and specificity, but measurement of α–sAPP represents a new and promising diagnostic marker.Keywords
This publication has 18 references indexed in Scilit:
- Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation.Proceedings of the National Academy of Sciences, 1994
- Increased β‐amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP670/671 mutationFEBS Letters, 1994
- An Increased Percentage of Long Amyloid β Protein Secreted by Familial Amyloid β Protein Precursor (βApp 717 ) MutantsScience, 1994
- Physiological production of the β-amyloid protein and the mechanism of Alzheimer's diseaseTrends in Neurosciences, 1993
- Release of Excess Amyloid β Protein from a Mutant Amyloid β Protein PrecursorScience, 1993
- Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein productionNature, 1992
- Isolation and quantification of soluble Alzheimer's β-peptide from biological fluidsNature, 1992
- A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloidNature Genetics, 1992
- Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis–dutch type share a decrease in cerebrospinal fluid levels of amyloid β‐protein precursorAnnals of Neurology, 1992
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984